Kathleen M. Coerdt

Kathleen M. Coerdt

Auto-generated profile, based on publicly available information

Kathleen M. Coerdt

Georgetown University School of Medicine, Washington, DC

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2021 in Archives of Plastic Surgery
Verified
Journal Article
Open access
PDF file
KCKathleen M. Coerdt
Kathleen M. Coerdt
EZElizabeth G. Zolper
Elizabeth G. Zolper
ASAmy G. Starr
Amy G. Starr
KFKenneth L. Fan
Kenneth L. Fan
CAChristopher E. Attinger
Christopher E. Attinger
KEKaren K. Evans
Karen K. Evans
Mucormycosis is an invasive, rapidly progressive, life-threatening fungal infection, with a propensity for diabetic, immunosuppressed, and trauma patients. The classic rhinocerebral variation is most common in diabetic patients. While the cutaneous form is usually caused by direct inoculation in immunocompetent patients. Cutaneous mucormycosis manifests in soft tissue and risks involvement of underlying structures. Tibial osteomyelitis can also occur secondary to cutaneous mucormycosis but is rare. Limb salvage is typically successful after lower extremity cutaneous mucormycosis even when the bone is involved. Herein, we report two cases of lower extremity cutaneous mucormycosis in diabetic patients that presented as acute worsening of chronic pretibial ulcers. Despite aggressive antifungal therapy and surgical debridement, both ultimately required amputation. Such aggressive presentation has not been reported in the absence of major penetrating trauma, recent surgery, or burns.

16 April 2021 in African Health Sciences
Verified
Journal Article
Open access
PDF file
KCKathleen M Coerdt
Kathleen M Coerdt
Khachemoune AmorKhachemoune Amor
Khachemoune Amor
Background: Human coronaviruses (HCoVs) are one of the most common causes of the “common cold”. Some HCoV strains, however, can cause fatal respiratory disease. Some examples of these diseases are severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Coronavirus Disease 19 (COVID-19). This article will review the etiology, clinical features, diagnosis, and management of HCoVs. Methods: A systematic literature review was performed using the terms “human coronaviruses”, “MERS-CoV”, “SARS- CoV”, “SARS-CoV2”, “COVID-19”, and “common cold” in OVID MEDLINE, PubMed, and Cochrane Library. Findings: Most HCoVs cause mild upper respiratory infections which resolve with supportive care and no sequelae. In recent decades, however, there have been outbreaks of novel HCoVs that cause more severe disease. This is largely due to HCoVs having large genomes which undergo frequent recombination events, leading to the emergence of novel and more virulent strains of the virus. These severe respiratory illnesses can lead to acute respiratory distress requiring invasive intervention, such as mechanical ventilation. These severe infections can lead to long-lasting sequelae in patients. Scientists continue to investigate potential treatments for these viruses, though supportive care remains the gold standard. Scientists have succeeded in devel- oping numerous vaccines for the SARS-CoV-2 virus, and ongoing data collection and analysis will shed even more light on the next steps in fighting the COVID-19 pandemic. Conclusion: Due to the frequency of recombination events and the subsequent emergence of novel strains, HCoVs are be- coming more prevalent, making them a global health concern as they can lead to epidemics and pandemics. Understanding the epidemiology, etiology, clinical features, diagnosis, and management of HCoVs is important, especially during this worldwide pandemic. Keywords: Coronavirus; common cold; severe respiratory disease; COVID-19.

1 January 2021 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
KCKathleen M. Coerdt
Kathleen M. Coerdt
STSarah P. Todd
Sarah P. Todd
CDCynthia M. C. DeKlotz
Cynthia M. C. DeKlotz

17 April 2020 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
KCKathleen M. Coerdt
Kathleen M. Coerdt
EGEmily L. Guo
Emily L. Guo
KSKarl M. Saardi
Karl M. Saardi
KHKaiane A. Habeshian
Kaiane A. Habeshian

6 January 2020 in Journal of Dermatological Treatment
Verified
Journal Article
Closed access
KCKathleen M. Coerdt
Kathleen M. Coerdt
WHWasim Haidari
Wasim Haidari
WHWilliam W. Huang
William W. Huang
Steven R. FeldmanSteven R. Feldman
Steven R. Feldman
Objectives: Absolute risk and cost-benefit analyses are necessary to guide clinical decision making. The purpose of this study was to evaluate whether clinical recommendations in dermatology publications were supported by adequate evidence. We also assessed whether dermatology residents report sufficient evidence when they author publications. Methods: We analyzed the clinical cohort, case-control, and case series studies published in JAMA Dermatology and the Journal of American Academy of Dermatology from January 2018 to December 2018 for statistical significance, absolute associations, diagnostic and therapeutic clinical recommendations, and risk-benefit analysis. We also identified articles with a U.S. dermatology resident as first or second author. Results: We found that the majority of articles reported statistical significance, but only 3% included absolute risk analyses and none had risk-benefit analysis. Furthermore, the subset of studies with a dermatology resident as a primary author reported statistical significance in 42%, but none provided absolute risk or risk-benefit analyses. Conclusions: Reviewers need to be more aware of the evidentiary needs required for clinical recommendations, and dermatology residents may benefit from additional statistics training.